The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2.
[pdf-embedder url=”http://mcawarenessnz.org/wp-content/uploads/2016/01/Morelli_et_al-2014-International_Journal_of_Cancer.pdf”]
